Oral and Parenteral Therapeutic Options for Outpatient Urinary Infections Caused by Enterobacteriaceae Producing CTX-M Extended-Spectrum β-Lactamases-Reference-Cited by-同舟云学术

Oral and Parenteral Therapeutic Options for Outpatient Urinary Infections Caused by Enterobacteriaceae Producing CTX-M Extended-Spectrum β-Lactamases

Published:2009-03 Issue:3 Volume:53 Page:1278-1280
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Prakash Vidhya¹,Lewis James S.²,Herrera Monica L.³,Wickes Brian L.³,Jorgensen James H.²³⁴

Affiliation:

1. San Antonio Military Medical Center, Infectious Disease Service, San Antonio, Texas 78234

2. Department of Medicine, The University of Texas Health Science Center and Pharmacy Service, University Hospital, San Antonio, Texas 78229

3. Department of Microbiology and Immunology, The University of Texas Health Science Center, San Antonio, Texas 78229

4. Department of Pathology, The University of Texas Health Science Center, San Antonio, Texas 78229

Abstract

ABSTRACT Effective therapeutic options are needed for community-onset urinary tract infections due to Escherichia coli strains that produce CTX-M extended-spectrum β-lactamases. We examined 46 urinary isolates producing CTX-M against several oral or long-acting parenteral antimicrobial agents. Approximately 90% were susceptible to fosfomycin and to a combination of cefdinir plus amoxicillin-clavulanate. All were susceptible to ertapenem.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01519-08

Reference25 articles.

1. Alhambra, A., J. A. Cuadros, J. Cacho, J. L. Gómez-Garcés, and J. I. Alós. 2004. In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics. J. Antimicrob. Chemother.53:1090-1094.

2. Bonsu, B. K., L. Shuler, L. Sawicki, P. Dorst, and D. M. Cohen. 2006. Susceptibility of recent bacterial isolates to cefdinir and selected antibiotics among children with urinary tract infections. Acad. Emerg. Med.13:76-81.

3. Calbo, E., V. Romaní, M. Xercavins, L. Gómez, C. G. Vidal, S. Quintana, J. Vila, and J. Garau. 2006. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases. J. Antimicrob. Chemother.57:780-783.

4. Approved standard M7-A7. 2006

5. Supplement M100-S18. 2008

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for Measuring Fosfomycin Concentrations in Human Prostatic Tissue;Pharmaceutics;2024-05-17

2. Uropathogenic Escherichia coli in urinary tract infections;Molecular Medical Microbiology;2024

3. The Role of Urinary Nitrite in Predicting Bacterial Resistance in Urine Culture Analysis Among Patients With Uncomplicated Urinary Tract Infection;Cureus;2022-06-17

4. Prevalence and multidrug-resistant ESBL-producing E. coli in urinary tract infection cases of HIV patients attending Federal Teaching Hospital, Abakaliki, Nigeria;African Journal of Microbiology Research;2022-05-31

5. Efficacy of Combination Therapies for the Treatment of Multi-Drug Resistant Gram-Negative Bacterial Infections Based on Meta-Analyses;Antibiotics;2022-04-14